Bioiberica Highlights Heparin Research and Ingredient Security at CPHI Milan

Bioiberica, a global life science company, announces its return to CPHI Milan with a renewed mission to provide the high-quality, traceable and scientifi...

September 23, 2026 | Wednesday | News
NorahLux Launches Research Hub Covering More Than 10,000 Red Light Therapy Studies

NorahLux has launched the Red Light Therapy Research Hub, an interactive research tool designed to make studies on photobiomodulation easier to search an...

September 22, 2026 | Tuesday | News
Teva Reports Real-World Data Showing UZEDY Supports Treatment Continuity and Reduces Healthcare Utilization in Schizophrenia

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.  announced new real-world data evaluating treatment continuity, health...

September 21, 2026 | Monday | News
EB Development Plans Public Withdrawal Offer for Eurobio Scientific at €25.30 Per Share

EB Development, a company owned directly or indirectly by funds managed by IK Partners and former reference shareholders of Eurobio Scientific (FR0013240...

September 18, 2026 | Friday | News
Seeing Biologics in Action: The Next Frontier in Analytical Science

  As biologics and novel modalities become increasingly sophisticated, understanding molecular structure under controlled conditions tells only part ...

September 17, 2026 | Thursday | Interaction
FDA Grants Priority Review to Genentech’s Enspryng for Rare Autoimmune Disease MOGAD

If approved, Enspryng would be the first and only disease-modifying therapy for MOGAD (myelin oligodendrocyte glycoprotein antibody-associated diseas...

September 11, 2026 | Friday | News
Aptar Pharma Partners with Aceso Therapeutics to Advance Inhaled ASO for Cystic Fibrosis

-Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced a collaboration with Aceso Therapeutics, a...

September 09, 2026 | Wednesday | News
AES Cleanroom Technology Secures FM 4882 Approval for Low-Smoke Cleanroom Panels

AES Cleanroom Technology today announced that its modular wall and ceiling panel system has earned FM 4882 Approval, the standard governing low smoke gen...

September 09, 2026 | Wednesday | News
Stryker to Acquire ZuriMED, Expanding Rotator Cuff Augmentation Portfolio

Stryker, a global leader in medical technologies, announced it has signed a definitive agreement to acquire ZuriMED, a privately held company and develop...

September 02, 2026 | Wednesday | News
Leios Therapeutics Grants CMS Exclusive China Rights to 10XB-101 for Focal Fat Reduction

10XB-101 is a Novel Potential Best-in-Class Injectable Drug Being Developed for Focal Fat Reduction and Body Contouring  Second Major Regional Lice...

September 01, 2026 | Tuesday | News
Quoin Reports Positive Interim Phase 2/3 Results for QRX003 in Netherton Syndrome

Quoin Pharmaceuticals Ltd. (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and...

August 31, 2026 | Monday | News
Teva Bids to Acquire BioXcel’s Novel At-Home Neuroscience Treatment for Agitation

Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. announced it has made a bid to acquire an innovative neurosc...

August 31, 2026 | Monday | News
Thermo Fisher Scientific Launches Orbitrap Isora Mass Spectrometers for Molecular-Level Isotope Analysis

Thermo Fisher Scientific, the world leader in serving science, introduced the Thermo Scientific Orbitrap Isora Mass Spectrometer and Orbitrap Isora Pro M...

August 27, 2026 | Thursday | News
NeuroThera and Clearmind Advance MDMA-PEA Program With U.S. Patent Application Publication

SciSparc Ltd.(“Company” or “SciSparc”), announced that its  subsidiary, NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a ...

August 26, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close